Mounjaro Price Rises in the UK: What Actually Happened

Step 1: Understand what Eli Lilly actually changed

Before August 2025, Mounjaro's UK list price sat at roughly £122 per four-week pen regardless of dose. That changed on 1 September 2025 when Eli Lilly restructured pricing across the strength range. The impact was sharpest at the higher doses: the 15mg pen's list price rose to around £330, as widely reported at the time. Lower doses saw smaller but still meaningful increases.

List price is not the same as what a private clinic or online pharmacy charges you, providers set their own retail prices on top of the manufacturer's wholesale figure, and those vary. What the Lilly price rise did was compress the floor: it became much harder for any provider to absorb the increase and still charge the prices patients had been used to paying in 2024. If you want to understand how the Mounjaro cost rise has affected what patients actually pay at different doses, our dedicated page breaks down the figures in detail. The result is that typical private Mounjaro prices since September 2025 range roughly £149 to £375 per month depending on dose and provider, according to widely reported market data. These figures are hedged and move; treat them as orientation, not a guarantee of what you'll be quoted.

You can find a plain factual overview of tirzepatide on the NHS medicines page for tirzepatide, which sets out what it is and how it's used without the commercial noise.

Step 2: Look past the headline figure at what it actually includes

A question our prescribers hear most weeks goes roughly: "I've seen it cheaper elsewhere, is it the same medicine?" The honest answer is that the medicine itself is the same (it must be, if it's coming through the licensed UK supply chain), but the price comparison often isn't apples-to-apples.

Some headline prices cover the pen only. Consultation fees, prescription fees, and delivery charges are billed separately, sometimes that's a modest add-on, sometimes it's substantial. Aftercare (dose-increase reviews, safety checks before each repeat order, access to a prescriber when something doesn't feel right) may not be included at all, or gated behind a premium tier.

It's also worth knowing that the total cost of Mounjaro treatment is shaped by which dose you reach. Most people don't stay on 2.5mg; the prescriber titrates upward over weeks and months. A headline price quoted at the starter dose tells you very little about what you'll pay three months in. Look for providers who are transparent about pricing across the full dose range before you start, not after your first titration review.

Details on how private treatment pricing is structured more broadly are covered on our Mounjaro cost and pricing page.

Step 3: Understand where nume sits, and why

We are not the cheapest option. That's a deliberate choice, not an oversight. One price at nume covers the consultation, the prescription, the treatment itself, tracked next-working-day delivery with DPD, and full aftercare, there is no second invoice.

Every consultation is read by a named GPhC-registered Independent Prescriber on the day it arrives. Not a triage algorithm, not an auto-approval system, a clinician. Before any dose increase or repeat supply, your case is reviewed again. That infrastructure costs something to run properly. Our page on why Mounjaro prices are set to rise further explains the commercial pressures shaping the market and what they mean for patients choosing a provider. The gap between a bare-pen price and an all-in clinical service is now visible.

Our about page covers how the pharmacy is structured and regulated. Our clinical team page introduces the prescribers behind the reviews. You can also verify our GPhC-registered pharmacy at registration number 9012878 on the GPhC register, the regulator's own search, not a badge we've designed ourselves.

Current treatment pricing is shown on our treatment page; we don't list per-pen prices in editorial copy because prices in this market have moved and will move again.

Step 4: Why price is the wrong primary question for a prescription medicine

The MHRA has seized approximately 20 million doses of illegally traded weight-loss medicines (worth roughly £45 million) through enforcement activity in 2025 alone. In October 2025 a site manufacturing counterfeit tirzepatide pens was raided in Northampton. Fake pens have contained insulin; hospitalisations have followed. The MHRA's guidance is unambiguous: only obtain these medicines with a valid prescription from a pharmacy you can verify.

What that means in practice: a price that seems significantly lower than the £149–£375 range described above isn't necessarily a bargain, it may reflect a shorter supply chain, no real clinical oversight, or a product that isn't what it claims to be. Report suspected sellers via the MHRA's Yellow Card scheme, which handles counterfeit and suspect medicine reports alongside adverse reactions.

For more background on how the September 2025 changes played out in the market, our pages on the Mounjaro price rise and the September timing specifically cover the detail. If you're ready to discuss treatment, speak to our prescribers, the consultation is free, and the same-day clinical review means you're not waiting for a decision.